JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 355 JPY -0.89% Market Closed
Market Cap: ¥219.5B

JMDC Inc
Other Current Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

JMDC Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
JMDC Inc
TSE:4483
Other Current Assets
¥1.4B
CAGR 3-Years
23%
CAGR 5-Years
27%
CAGR 10-Years
N/A
M3 Inc
TSE:2413
Other Current Assets
¥12.4B
CAGR 3-Years
21%
CAGR 5-Years
20%
CAGR 10-Years
21%
S
Software Service Inc
TSE:3733
Other Current Assets
¥635m
CAGR 3-Years
33%
CAGR 5-Years
18%
CAGR 10-Years
19%
Medley Inc
TSE:4480
Other Current Assets
¥771m
CAGR 3-Years
27%
CAGR 5-Years
30%
CAGR 10-Years
N/A
CareNet Inc
TSE:2150
Other Current Assets
¥657.6m
CAGR 3-Years
56%
CAGR 5-Years
44%
CAGR 10-Years
24%
Medical Data Vision Co Ltd
TSE:3902
Other Current Assets
¥499.4m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
24%
No Stocks Found

JMDC Inc
Glance View

Market Cap
219.5B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 968.52 JPY
Undervaluation 15%
Intrinsic Value
Price ¥3 355

See Also

What is JMDC Inc's Other Current Assets?
Other Current Assets
1.4B JPY

Based on the financial report for Dec 31, 2025, JMDC Inc's Other Current Assets amounts to 1.4B JPY.

What is JMDC Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
27%

Over the last year, the Other Current Assets growth was 35%. The average annual Other Current Assets growth rates for JMDC Inc have been 23% over the past three years , 27% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett